Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2006-05-04 (20 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BETHUNE (62400), Pas-de-Calais
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DU MONT LIEBAUT : revenue, balance sheet and financial ratios
PHARMACIE DU MONT LIEBAUT is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BETHUNE (62400),
this company of category PME
shows in 2022 a revenue of 2.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU MONT LIEBAUT (SIREN 490016268)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
2 368 616 €
N/C
N/C
N/C
N/C
N/C
N/C
Net income
334 230 €
224 679 €
194 590 €
239 880 €
117 395 €
112 812 €
102 421 €
99 224 €
165 461 €
EBITDA
N/C
N/C
272 278 €
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
8.2%
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DU MONT LIEBAUT generates positive net income of 334 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 165 k€ -> 334 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
334 230 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 48%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 57%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
48.5%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
57.161%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DU MONT LIEBAUT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
275.243
203.427
162.202
130.727
88.746
61.887
57.676
43.007
48.5
Financial autonomy
24.215
29.829
34.983
40.031
48.037
55.093
54.349
58.677
57.161
Repayment capacity
None
None
None
None
None
None
3.418
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
8.395%
None%
None%
Sector positioning
Debt ratio
48.52024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good
In 2024, the debt ratio of PHARMACIE DU MONT LIEBAUT (48.50) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
57.16%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good
In 2024, the financial autonomy of PHARMACIE DU MONT LIEBAUT (57.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
3.42 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Good
In 2022, the repayment capacity of PHARMACIE DU MONT LIEBAUT (3.42) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 148.75. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
148.754
Liquidity indicators evolution PHARMACIE DU MONT LIEBAUT
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
294.781
228.472
256.259
250.512
168.074
0.0
0.0
122.786
148.754
Interest coverage
None
None
None
None
None
None
4.019
None
None
Sector positioning
Liquidity ratio
148.752024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average+32 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DU MONT LIEBAUT (148.75) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
4.02x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Good
In 2022, the interest coverage of PHARMACIE DU MONT LIEBAUT (4.0x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU MONT LIEBAUT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
-45 714 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
0
0
0
Customer payment term (days)
0
0
0
0
0
0
0
0
0
Supplier payment term (days)
0
0
0
0
0
0
53
0
0
Positioning of PHARMACIE DU MONT LIEBAUT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DU MONT LIEBAUT is estimated at
4 666 097 €
(range 3 249 396€ - 6 980 749€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
3249k€4666k€6980k€
4 666 097 €Range: 3 249 396€ - 6 980 749€
NAF 5 année 2024
Valuation method used
Net Income Multiple
334 230 €
×
14.0x
=4 666 098 €
Range: 3 249 397€ - 6 980 749€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU MONT LIEBAUT with other companies in the same sector:
Frequently asked questions about PHARMACIE DU MONT LIEBAUT
What is the revenue of PHARMACIE DU MONT LIEBAUT ?
The revenue of PHARMACIE DU MONT LIEBAUT in 2022 is 2.4 M€.
Is PHARMACIE DU MONT LIEBAUT profitable?
Yes, PHARMACIE DU MONT LIEBAUT generated a net profit of 334 k€ in 2024.
Where is the headquarters of PHARMACIE DU MONT LIEBAUT ?
The headquarters of PHARMACIE DU MONT LIEBAUT is located in BETHUNE (62400), in the department Pas-de-Calais.
Where to find the tax return of PHARMACIE DU MONT LIEBAUT ?
The tax return of PHARMACIE DU MONT LIEBAUT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU MONT LIEBAUT operate?
PHARMACIE DU MONT LIEBAUT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart